Cite
The role of the thioredoxin/thioredoxin reductase system in the metabolic syndrome: towards a possible prognostic marker?
MLA
Tinkov, Alexey A., et al. “The Role of the Thioredoxin/Thioredoxin Reductase System in the Metabolic Syndrome: Towards a Possible Prognostic Marker?” Cellular & Molecular Life Sciences, vol. 75, no. 9, May 2018, pp. 1567–86. EBSCOhost, https://doi.org/10.1007/s00018-018-2745-8.
APA
Tinkov, A. A., Bjørklund, G., Skalny, A. V., Holmgren, A., Skalnaya, M. G., Chirumbolo, S., & Aaseth, J. (2018). The role of the thioredoxin/thioredoxin reductase system in the metabolic syndrome: towards a possible prognostic marker? Cellular & Molecular Life Sciences, 75(9), 1567–1586. https://doi.org/10.1007/s00018-018-2745-8
Chicago
Tinkov, Alexey A., Geir Bjørklund, Anatoly V. Skalny, Arne Holmgren, Margarita G. Skalnaya, Salvatore Chirumbolo, and Jan Aaseth. 2018. “The Role of the Thioredoxin/Thioredoxin Reductase System in the Metabolic Syndrome: Towards a Possible Prognostic Marker?” Cellular & Molecular Life Sciences 75 (9): 1567–86. doi:10.1007/s00018-018-2745-8.